Novel Strategies in the Development of New Therapies, Drug Substances, and Drug Carriers Volume II

被引：0
|
作者：
Kutner, Andrzej [1 ]
Brown, Geoffrey [2 ]
Kallay, Eniko [3 ]
机构：
[1] Med Univ Warsaw, Fac Pharm, Dept Drug Chem, 1 Banacha, PL-02097 Warsaw, Poland
[2] Univ Birmingham, Inst Clin Sci, Coll Med & Dent Sci, Sch Biomed Sci, Birmingham B15 2TT, England
[3] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Wahringer Gurtel 18-20, A-1090 Vienna, Austria
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2023年 / 24卷 / 06期
关键词：
D O I：
10.3390/ijms24065621
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：8
相关论文
共 50 条
  • [31] Novel drug therapies for atrial fibrillation
    Felix Wiedmann
    Constanze Schmidt
    Nature Reviews Cardiology, 2024, 21 : 275 - 276
  • [32] Drug Resistance and Novel Therapies in Cancers
    Wang, Zhixiang
    CANCERS, 2020, 12 (10)
  • [33] Posterior Segment Drug Delivery Devices: Current and Novel Therapies in Development
    Bansal, Pooja
    Garg, Satpal
    Sharma, Yograj
    Venkatesh, Pradeep
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2016, 32 (03) : 135 - 144
  • [34] DRUG DEVELOPMENT T-cell therapies aimed at novel coronavirus
    Cross, Ryan
    CHEMICAL & ENGINEERING NEWS, 2020, 98 (12) : 17 - 17
  • [35] Novel drug therapies for atrial fibrillation
    Wiedmann, Felix
    Schmidt, Constanze
    NATURE REVIEWS CARDIOLOGY, 2024, 21 (05) : 275 - 276
  • [36] Novel drug therapies for heart failure
    Hobbs, R.
    ADVANCES IN HEART DISEASE, 2006, : 479 - 482
  • [37] Novel Drug Therapies in the Treatment of SAH
    Karri, Surya
    Ogilvy, Christopher S.
    CURRENT DRUG SAFETY, 2012, 7 (03) : 189 - 189
  • [38] Novel drug therapies in myeloid leukemia
    Horne, Gillian A.
    Kinstrie, Ross
    Copland, Mhairi
    PHARMACEUTICAL PATENT ANALYST, 2015, 4 (03) : 187 - 205
  • [39] New Era for Novel CNS Drug Development
    William Z Potter
    Neuropsychopharmacology, 2012, 37 : 278 - 280
  • [40] New Era for Novel CNS Drug Development
    Potter, William Z.
    NEUROPSYCHOPHARMACOLOGY, 2012, 37 (01) : 278 - 280
12345